Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Mesothelioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Robert Ripley, MD

    Principal Investigator

    Baylor College of Medicine